BACKGROUND: Immediate postpartum levonorgestrel intrauterine device insertion is increasing in frequency in the United States, but few studies have investigated the effect of early placement on breast-feeding outcomes.
Introduction
Breast-feeding provides health benefits to women and infants. 1 The World Health Organization recommends exclusive breast-feeding for 6 months postpartum and continuation of breast-feeding through 2 years as a best practice for infant nutrition and maternal health. 2 Although 80% of US women plan to breast-feed, 3 only 18.8% exclusively breast-feed at 6 months, short of the Centers for Disease Control and Prevention (CDC) Healthy People 2020 objective of 25%. 4 Postpartum women are frequently motivated to prevent pregnancy and may appreciate the convenience of initiating a highly effective contraceptive method in the hospital rather than waiting for a postpartum visit. 5, 6 Women receiving immediate postpartum intrauterine devices (IUDs) report high satisfaction, and continuation rates. 7 When the levonorgestrel (LNG) IUD is placed immediately postpartum there is a significantly higher rate of expulsion compared to women initiating the IUD at the postpartum visit. 8 Despite the higher expulsion with immediate postpartum Original Research ajog.org placement, accounting for replacement of expelled IUDs, continuation rates at 6 and 12 months are similar to those in women initiating the IUD at the postpartum visit. 7 The advantages of immediate postpartum IUD placement, including preventing unintended pregnancy, 9 must be weighed against potential drawbacks. Rapid clearance of progesterone after placental delivery triggers lactogenesis, raising concerns that immediate postpartum initiation of the progestin-secreting LNG IUD could disrupt lactogenesis and reduce breast milk production, 10 even though LNG is an androgen derivative and not a true progestin. Providers often discourage immediate initiation of hormonal contraception, including the LNG IUD, due to concerns of a negative impact on breast-feeding, 11 but data on the effect of hormonal intrauterine contraception on breastfeeding are limited. 12 Some studies assessing early exposure to oral contraception 13 and in-hospital postpartum etonogestrel implant insertion 14 have shown no adverse effect on lactation. These results prompted our use of a noninferiority design for the current study.
Based on minimal evidence, the CDC Medical Eligibility Criteria for Contraceptive Use assign a category 2 rating (the advantages generally outweigh the theoretical or proven risks) to immediate postpartum LNG IUD initiation in breast-feeding women. 15 This study assesses the effect of immediate vs delayed postpartum initiation of LNG IUD on breast-feeding outcomes. The primary outcome was report of any breastfeeding at 8 weeks' postpartum.
Materials and Methods

Trial design and oversight
The Breastfeeding LNG IUD Study, a noninferiority randomized controlled trial, was conducted at the University of Utah and the University of New Mexico Health Sciences Centers from February 2014 through March 2016. Each site's institutional review board approved the study (Clinicaltrials.gov registry number NCT01990703).
Study procedures
Study staff approached and enrolled potential participants during prenatal care who expressed intent to breastfeed and desired a LNG IUD for postpartum contraception. Eligible women presenting for induction of labor or in early, but not active, labor were also approached on labor and delivery.
Potential participants received standardized counseling about the risks and benefits of immediate postpartum vs delayed LNG IUD insertion, including increased risk of IUD expulsion and unknown effect of LNG IUD on breast-feeding with immediate postpartum insertion. After screening for eligibility and obtaining informed consent, a clinical research team member enrolled participants. Baseline data included age, gravidity, parity, contraceptive history, and breast-feeding experience.
Eligible participants included healthy pregnant women fluent in English or Spanish aged 18-40 years, who desired the LNG IUD as their postpartum method of contraception, planned to breast-feed, and agreed to randomization of LNG IUD placement timing. Prespecified exclusion criteria included delivery <37.0 weeks' gestational age, clinical chorioamnionitis, postpartum hemorrhage, preeclampsia with severe features, prolonged antepartum hospitalization, coagulopathy, hepatic disease, undiagnosed genital bleeding, or relative contraindications to LNG IUD insertion.
Randomization with equal (1:1) probability of assignment to the immediate or delayed group occurred via computerized block randomization with alternating block sizes of 4, 6, and 8. The lead statistician (J.N.S.) generated treatment assignments for each institution that were stored in secure spreadsheet software files and uploaded into the Research Electronic Data Capture program, a secure Webbased application, 16 which was also used for electronic data collection and data entry. Random assignment to one of the treatment groups occurred on the labor and delivery unit at the time of presentation for delivery. The provider contacted a site research coordinator to obtain assignment information. Participants and clinicians were not blinded to intervention assignment; the data analysis team remained blinded.
Intervention
Both sites conducted didactic training on immediate postpartum IUD insertion with model-based simulation. At the New Mexico site providers completed a certification process with 3-5 insertions performed under direct supervision of a certified attending physician. The Utah site required supervision by an experienced attending physician until trainees were determined to be competent. New Mexico providers used standard 2-ring forceps insertion technique (1 on anterior cervical lip, 1 holding IUD); the Utah site encouraged insertions with Kelly placenta forceps to hold the IUD and permitted hand placement. These practice variations were not expected to affect study outcomes.
All immediate postpartum IUD insertions were performed by obstetrician-gynecology and family medicine physicians following delivery of the placenta with a goal of placement within 30 minutes. Although not required, physicians routinely used ultrasound guidance for insertions after vaginal delivery. Women in the immediate group returned at 2-4 weeks' postpartum to confirm IUD retention. Delayed insertions occurred at the participant's usual clinic by an experienced provider 4-12 weeks' postpartum.
Following enrollment, randomization, and delivery of a healthy term infant, the clinical research coordinators at each site contacted their respective site participants twice daily prior to hospital discharge. Time to lactogenesis was documented by maternal perception, as described and validated by Chapman and Perez-Escamilla 17 and used in a prior study conducted at the Utah site.
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Consolidated Standards of Reporting Trials (CONSORT) flow chart
Number of women assessed for eligibility (N=453)
Primary Outcome: 8-weeks (n=112)
• Breasƞeeding (n=88; 79% 95%CI 70%-86%)
• Not breasƞeeding (n=24; 22%)
• Lost to follow up (n=13)
Delayed (n=138)
Immediate (n=147)
Primary Outcomes: 8-weeks (n=102)
• Breasƞeeding (n=86; 84% 95%CI 76%-91%)
• Not breasƞeeding (n=16; 16%)
• Lost to follow up (n=1)
Explatory Outcome: 6-months (n=93)
• Breasƞeeding (n=56; 60% 95%CI 50%-70%)
• Not Breasƞeeding (n=37; 40%)
• Lost to follow up (n=10)
Exploratory Outcome: 6-months (n=108)
• Breasƞeeding (n=55; 51% 95%CI 41%-61%)
• Not Breasƞeeding (n=53; 49%)
• Lost to follow up (n=17)
Enrollment
Secondary Outcome: Lactogenesis (n=125)
• LactaƟon "Delay" > 120 hours (n=11; 9%)
• Complete LactaƟon Failure (n=2; 2%)
• Lactaion >120h w/bf (n=9; 7%)
Secondary Outcome: Lactogenesis (n=103)
• LactaƟon "Delay" > 120 hours (n=6; 6%)
• Complete LactaƟon Failure (n=0; 0%)
• Lactaion >120h w/bf (n=6; 6%)
Allocation
Inent-to-treat Immediate (n = 132)
Did not receive Immediate IUD (n=7)
Intent-to-treat Delayed (n = 127) Did not receive delayed IUD 4-12 weeks (n=24)
Follow-Up
Received Immediate IUD (n=125)
• IUD expulsions (n=24; 19%)
• IUD removal (n=0)
Lost to follow-up or withdrew consent: @ 8-weeks (n=13)
Received Delayed IUD (n=103)
• IUD expulsions (n=2; 2%)
• IUD removal (n=2)
Lost to follow-up or withdrew consent: @ 8-weeks (n=1)
Per Protocol Analysis
Immediate (n = 125)
Delayed (n = 103)
Number of women delivered and not randomized (n=34)
• Missed RandomizaƟon (n=14)
• Delivered at different Hospital (n=7)
• Missed randomizaƟon at study hospital (n=7)
Did not receive allocated intervenƟon due to Medical complicaƟons (n=15)
Did not receive allocated intervenƟon due to Medical complicaƟons (n=11)
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prior to hospital discharge, the participant received daily text messages or telephone calls from study personnel up to 5 days postpartum until lactogenesis was confirmed and recorded. Delayed lactation was defined as lack of production of breast milk by 120 hours postpartum as assessed by maternal perception. Lactation failure was defined as no breast milk production by 2 weeks' postpartum. Study staff contacted participants by telephone, text messaging, or electronic communication weekly from 2-12 weeks' postpartum to collect data on breast-feeding continuation, type of breast-feeding (exclusive breast-feeding, breast-feeding and pumping, or breastfeeding with supplementation), and date of cessation, if applicable. Participants were evaluated in-person at the prearranged postpartum visit. There was a final follow-up at 6 months' postpartum. We also tracked contraceptive method use, including dates of expulsions and reinsertions if they occurred, method satisfaction, and adverse events including any hospitalizations or events related to IUD use.
Participants were not charged for IUDs or insertion procedures. Due to lack of Medicaid and private insurance reimbursement for in-hospital placement in Utah, the site only offered enrollment to women who qualified through an externally funded training grant for uninsured women. For women who had coverage in New Mexico, Medicaid or private insurance was billed for the insertion procedure. In the event of IUD expulsion or desired removal, clinic personnel counseled participants on options for reinsertion or contraceptive alternatives. We billed these visits to insurance and for uninsured women the study covered the charge.
Sample size
Based on a prior New Mexico study, we expected 60% of women with delayed initiation of hormonal contraception to continue breastfeeding at 8 weeks' postpartum. 13 We chose any breast-feeding at 8 weeks' 
Statistical analysis
We summarized the demographic characteristics and the primary outcome of breast-feeding continuation and the secondary outcome of lactogenesis and assessed the differences between assigned groups using Pearson c 2 test or binomial 95% confidence intervals (CI) for categorical variables and Wilcoxon rank sum test or Student t test for continuous variables. The per-protocol analysis is presented as the primary approach throughout the article; it is considered the gold standard in noninferiority trials, as it is more conservative than the intent-to-treat approach. 18, 19 We also report outcomes using intent-totreat analysis.
Per-protocol analysis included women who received their treatment according to the prespecified protocol. For the immediate group, per-protocol analysis included participants who received immediate postpartum IUD insertion with any immediate exposure; this includes individuals with IUD expulsion prior to 8-week follow-up. For the delayed group, per-protocol analysis included only women with documented receipt of a delayed postpartum IUD (at 4-12 weeks). The intent-to-treat analysis included all women who were randomized and did not develop a medical complication leading to exclusion prior to delivery. In both the intent-to-treat and per-protocol analyses breast-feeding rates were compared using the 1-sided c 2 test of noninferiority. If the CI did not cross the prespecified 15% margin, noninferiority was confirmed. 19 The secondary outcome of lactogenesis was assessed using a survival analysis and log-rank test to compare the survival distributions timing of lactogenesis between groups, including individuals with delayed lactogenesis, defined as milk coming in >120 hours. Mean times to lactogenesis are reported excluding those individuals who had delayed lactogenesis or lactation failure.
We also conducted post hoc exploratory analyses of the treatment effect (immediate postpartum insertion vs delayed IUD insertion) on outcomes up to 6 months postpartum, including any or exclusive breast-feeding, IUD expulsion, and patient satisfaction with the timing of LNG IUD insertion. For satisfaction, we employed a 0-to-100 scale assessing "how happy are you with the IUD received" (anchors of 0 "not happy at all" to 100 "very happy") assessed by Pearson c 2 test, or Fisher exact test as appropriate. In addition, we asked participants their perception of optimal timing for insertion of a contraceptive relative to a birth. Response options included "in the hospital at the time of birth," "4 weeks after the birth," "at a 6-week postpartum exam," or "at another clinic visit 6-8 weeks after birth." We used software (STATA 14; StataCorp LP, College Station, TX) for statistical analysis.
Results
Participant characteristics
From February 2014 through March 2016, we assessed 453 women for eligibility; 319 consented to study participation and enrolled. Enrollment ceased when the target number of participants had consented to participation. The Any breast-feeding reported from 2 weeks to 6 months postpartum Curve demonstrates noninferiority for primary outcome of any breast-feeding at 8 weeks as point estimate for 8-week breast-feeding continuation for early group falls within 15% of upper end of 95% confidence interval for late insertion group. ajog.org GYNECOLOGY Original Research details regarding the 34 (11%) nonrandomized participants are included in Figure 1 . Randomization assigned 147 women to the immediate and 138 women to the delayed group. The Table includes all randomized participants who were not excluded for medical complications prior to delivery. There were no differences between the 2 groups of baseline and demographic characteristics.
After randomization, 26 women experienced medical complications during labor and delivery and were excluded from both analytic approaches. In all, 22 women in the immediate group and 35 in the delayed group did not receive their allocated intervention. Postrandomization exclusion criteria for per-protocol analysis included protocol violations and participant withdrawals prior to hospital discharge. We retained data for women in the delayed insertion group who were lost to follow-up or withdrew from the study after primary outcome data were collected 20 ( Figure 1 ). Per-protocol assessment included 228 women who completed the assigned treatment (125 in the immediate and 103 in the delayed group). A total of 259 participants were included in the intent-to-treat analysis (132 women in the immediate and 127 in the delayed group).
Primary outcome: 8-week breastfeeding continuation
Per-protocol analysis demonstrated noninferiority between immediate postpartum LNG IUD insertion and delayed insertion for the primary outcome of any breast-feeding at 8 weeks: 79% (95% CI, 70e86%) vs 84% (95% CI, 76e91%) (P ¼ .28) (Figure 2) . Intent-to-treat analysis demonstrated similar findings: 78% (95% CI, 70e85%) and 83% (95% CI, 75e90%) (P ¼ .36) of women in the 2 groups, respectively, who continued breastfeeding at 8 weeks. The 5% difference in breast-feeding continuation at 8 weeks between the groups fell within the noninferiority margin (95% CI, e5.6 to 15%). A Cox proportional hazard ratio model controlling for randomization, site, age, ethnicity, epidural, and parity showed no significant associations between these factors and the primary outcome measure.
Secondary outcome: time to lactogenesis
Survival distributions of time to lactogenesis for both groups are illustrated in the Kaplan-Meier survival curve (Figure 3) . The distributions of time to lactogenesis did not differ between groups as evaluated by the log-rank test (P ¼ .22) (Figure 3) . Mean times to lactogenesis, excluding women with delayed lactation, occurred at (mean AE SD) 65.3 AE 25.7 hours for the immediate group and 63.6 AE 21.7 hours for the delayed group. The mean difference was 1.7 hours (95% CI, e4.8 to 8.2 hours; P ¼ .61). Delayed lactation occurred in 11 women (9%) in the immediate group and 6 (6%) in the delayed group (P ¼ .46). Two women experienced complete lactogenesis failure in the per-protocol approach, both in the immediate group.
Post hoc exploratory outcomes
For the exploratory outcome of exclusive breast-feeding at 8 weeks, defined as no breast milk pumping, formula supplementation, or use of solid foods, the perprotocol analysis found no significant differences between the immediate and delayed groups: 33% (95% CI, 24e43%) and 40% (95% CI, 31e51%) (P ¼ .27) (Figure 4) . IUD expulsions were more common in the immediate postpartum (24/125 [19%] ) compared to the delayed (2/103 [2%]) group. The majority of women in the immediate postpartum group (17/24 [71%]) who experienced IUD expulsion requested and received IUD reinsertion at their postpartum clinic visit. Both groups reported high 3-and 6-month satisfaction rates. The average satisfaction score measured at 12 weeks' postpartum on a 0-to-100 scale among the immediate postpartum group was 86 (95% CI, 80e91%) and in the delayed group was 87 (95% CI, 79e96%). When participants completed the 12-week questionnaire, 80% in the immediate postpartum group and 42% in the delayed group responded that, "in the hospital at the time of birth is the perfect time to have a birth control device placed." Original Research GYNECOLOGY ajog.org
Safety monitoring
No uterine perforations or uterine infections were reported in this study either with immediate postpartum or delayed IUD insertion.
Comment
This randomized controlled trial demonstrated that breast-feeding outcomes in women with immediate postpartum LNG IUD insertion were noninferior to those in women with delayed insertion. This study further supports prior literature showing no adverse effect of progestin-only contraceptives on lactation, 20 and high levels of contraceptive satisfaction for women in both groups. 7 The limited data evaluating potential harms of immediate postpartum initiation of progestin-only contraceptives on lactation show mixed results. A systematic review of progestin-only contraceptives demonstrated no adverse effects on breast-feeding or infant outcomes, 21 while a secondary analysis of 59 breast-feeding women randomized to immediate postpartum vs delayed LNG IUD insertion found that fewer women in the immediate insertion group breast-fed at 6 months. 12 A randomized trial of inhospital postpartum etonogestrel implant insertion compared with standard postpartum insertion found no differences in time to lactogenesis, formula supplementation, or milk composition, similar to the findings of the current study.
14 A nonrandomized prospective trial compared women initiating progestin-only methods (mostly depo medroxyprogesterone acetate) within the first 3 postpartum days with women using nonhormonal methods and found no differences in breast-feeding outcomes. 22 Major strengths of our study include its randomized controlled design, use of study sites that had incorporated the intervention into routine care prior to study initiation, and lack of industry sponsorship. Study endpoints of breast-feeding continuation and lactogenesis are clinically relevant.
Study limitations include lack of ability to blind the timing of LNG IUD placement, loss to follow-up, lack of long-term infant and childhood outcomes, and limited applicability as we included only women having a term birth. Because we did not collect data on breast milk volume per feeding and the number and duration of breast-feeding sessions, we did not specifically address whether early postpartum exposure to a LNG IUD decreases milk production. 23 Challenges to internal validity include a smaller final sample than intended despite meeting enrollment goals. The smaller sample size resulted from a greater than expected number of exclusions both after enrollment and postrandomization. An additional challenge to internal validity resulted from loss to follow-up of 12 of the 13 participants in the early insertion group who had IUD expulsions. The omission of these immediate insertion participants from the primary outcome could potentially widen the CI of the per-protocol analysis, resulting in a more conservative estimate of the noninferiority result. Our sample size was insufficient to power 2 important subgroup analyses. Nearly three quarters of participants had prior breast-feeding experience, although we were unable to assess differences in continuation based on prior breastfeeding. Our ability to assess lactation failure was limited given the rarity of the outcome in our sample. Another study limitation comes from a strength in our hospitals: both sites have Baby-Friendly Hospital Initiative accreditation. 24 This supportive breast-feeding environment may have independently contributed to attainment of the CDC Healthy People 2020 objective of 25% of mothers exclusively breast-feeding at 6 months postpartum. 4 Effective contraception reduces rapid repeat pregnancies and poor perinatal outcomes. 25 In one study, 42% of women were interested in initiating implants and IUDs immediately postpartum. 6 However, many women do not return for postpartum follow-up appointments or become pregnant prior to the visit and Report of exclusive breast-feeding out to 6 months Exclusive breast-feeding between groups differed slightly at 8 weeks but this resolved by 6 months. ajog.org GYNECOLOGY Original Research only 81% of women randomized to delayed postpartum IUD insertion ultimately received the device, reflecting barriers inherent in deferring contraceptive initiation. 26, 27 Similarly, in this study 24 women assigned to delayed insertion did not return for IUD insertion and 9 participants received their IUD beyond the primary study outcome timeline of 8 weeks' postpartum. Those women had no exogenous hormonal exposure and avoided any potential negative influence on breast-feeding in the control group, biasing our results toward a larger difference if one had existed. Earlier initiation of hormonal contraception in the immediate postpartum period is a patientcentered strategy to meet women's contraceptive needs.
In many settings, concerns about harmful effects on lactation may currently limit placement of immediate postpartum contraception. This study provides further reassurance that progestin-only contraceptives are unlikely to have a negative impact on breast-feeding. We recommend that immediate postpartum LNG IUD initiation become a standard contraceptive option discussed with pregnant women, regardless of intention to breast-feed. n
